Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Beule, Dieter Dr. (1) Blankenstein, Thomas Prof. Dr. (1) Blüthgen, Nils (1) Edes, Inan Dr. (1) Kammertöns, Thomas Dr. (1) Kobelt, Dennis Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (5) Rajewsky, Klaus Prof. Dr. (1) Wollert-Wulf, Brigitte (2) (-) Daniel, Peter Prof. Dr. (1) (-) Janz, Martin Dr. (6) (-) Leisegang, Matthias Dr. (4) (-) Uckert, Wolfgang Prof. Dr. (6) 2003 (8) 2004 (6) 2005 (6) (-) 2006 (7) 2007 (7) 2008 (5) 2009 (6) 2010 (10) 2011 (7) (-) 2012 (6) 2013 (7) 2014 (9) 2015 (9) 2016 (11) 2017 (7) 2018 (4) 2019 (1) 2020 (6) 2021 (7) 2022 (7) (-) Biology of Malignant Lymphomas (6) Epigenetic Regulation and Chromatin Architecture (1) Genetics and Genomics of Cardiovascular Diseases (1) Immune Regulation and Cancer (1) (-) Molecular Cell Biology and Gene Therapy (8) Molecular Immunology and Gene Therapy (1) Myology (1) Proteome Dynamics (6) RNA Biology and Posttranscriptional Regulation (1) Translational Oncology of Solid Tumors (1) 13 Results: Active Filter: Daniel, Peter Prof. Dr.Janz, Martin Dr.Leisegang, Matthias Dr.Uckert, Wolfgang Prof. Dr.Biology of Malignant LymphomasMolecular Cell Biology and Gene Therapy20062012 Sort: Result score Newest to oldest Oldest to newest November 22, 2012 in Blood T cell receptor gene transfer exclusively to human CD8+ cells enhances tumor cell killing Q. Zhou I.C. Schneider I. Edes A. Honegger P. Bach K. Schoenfeld A. Schambach W.S. Wels S. Kneissl W. Uckert C.J. Buchholz November 01, 2012 in Nat Immunol The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers D.P. Calado Y. Sasaki S.A. Godinho A. Pellerin K. Köchert B.P. Sleckman I.M. de Alboran M. Janz S. Rodig K. Rajewsky October 01, 2012 in J Virol Protective capacity of virus-specific T cell receptor (TCR)-transduced CD8 T cells in vivo K. Mueller A. von Maessenhausen U. Aichele L. Staerck M. Leisegang W. Uckert H. Pircher August 01, 2012 in Br J Dermatol The tumour suppressor p53 is frequently nonfunctional in Sezary syndrome B. Lamprecht S. Kreher M. Moebs W. Sterry B. Doerken M. Janz C. Assaf S. Mathas July 15, 2012 in J Immunol Human antitumor CD8+ T cells producing Th1 polycytokines show superior antigen sensitivity and tumor recognition S. Wilde D. Sommermeyer M. Leisegang B. Frankenberger B. Mosetter W. Uckert D.J. Schendel April 12, 2012 in Blood TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo S. Spranger I. Jeremias S. Wilde M. Leisegang L. Staerck B. Mosetter W. Uckert M.H.M. Heemskerk D.J. Schendel B. Frankenberger November 01, 2006 in Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert May 15, 2006 in Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas April 01, 2006 in Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel March 15, 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou Pagination Current page 1 Page 2 Next page Next › Last page Last »
November 22, 2012 in Blood T cell receptor gene transfer exclusively to human CD8+ cells enhances tumor cell killing Q. Zhou I.C. Schneider I. Edes A. Honegger P. Bach K. Schoenfeld A. Schambach W.S. Wels S. Kneissl W. Uckert C.J. Buchholz
November 01, 2012 in Nat Immunol The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers D.P. Calado Y. Sasaki S.A. Godinho A. Pellerin K. Köchert B.P. Sleckman I.M. de Alboran M. Janz S. Rodig K. Rajewsky
October 01, 2012 in J Virol Protective capacity of virus-specific T cell receptor (TCR)-transduced CD8 T cells in vivo K. Mueller A. von Maessenhausen U. Aichele L. Staerck M. Leisegang W. Uckert H. Pircher
August 01, 2012 in Br J Dermatol The tumour suppressor p53 is frequently nonfunctional in Sezary syndrome B. Lamprecht S. Kreher M. Moebs W. Sterry B. Doerken M. Janz C. Assaf S. Mathas
July 15, 2012 in J Immunol Human antitumor CD8+ T cells producing Th1 polycytokines show superior antigen sensitivity and tumor recognition S. Wilde D. Sommermeyer M. Leisegang B. Frankenberger B. Mosetter W. Uckert D.J. Schendel
April 12, 2012 in Blood TCR-transgenic lymphocytes specific for HMMR/Rhamm limit tumor outgrowth in vivo S. Spranger I. Jeremias S. Wilde M. Leisegang L. Staerck B. Mosetter W. Uckert M.H.M. Heemskerk D.J. Schendel B. Frankenberger
November 01, 2006 in Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
May 15, 2006 in Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
April 01, 2006 in Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
March 15, 2006 in Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
